These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4282557)

  • 21. Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington's chorea.
    Yates CM; Magill BE; Davidson D; Murray LG; Wilson H; Pullar IA
    Clin Chim Acta; 1973 Feb; 44(1):139-45. PubMed ID: 4267642
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurotransmitter precursors and metabolites in CSF of human neonates.
    Anderson GM; Hoder EL; Shaywitz BA; Cohen DJ
    Dev Med Child Neurol; 1985 Apr; 27(2):207-14. PubMed ID: 2581835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid.
    Sack RL; Goodwin FK
    Arch Gen Psychiatry; 1974 Nov; 31(5):649-54. PubMed ID: 4613319
    [No Abstract]   [Full Text] [Related]  

  • 24. Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
    Ackenheil M; Beckmann H; Greil W; Hoffmann G; Markianos E; Raese J
    Adv Biochem Psychopharmacol; 1974; 9(0):647-57. PubMed ID: 4836227
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram.
    Lake CR; Major LF; Ziegler MG; Kopin IJ
    Am J Psychiatry; 1977 Dec; 134(12):1411-4. PubMed ID: 920841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Several biochemical mechanisms of the pathogenesis of Huntington chorea].
    Barkhatova VP; Larskiĭ EG; Markova ED; Ivanova-Smolenskaia IA; Insarova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(7):1038-45. PubMed ID: 6137919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study.
    Oxenstierna G; Edman G; Iselius L; Oreland L; Ross SB; Sedvall G
    J Psychiatr Res; 1986; 20(1):19-29. PubMed ID: 2423688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemistry of the augmenting-reducing response in visual evoked potentials.
    von Knorring L; Perris C
    Neuropsychobiology; 1981; 7(1):1-8. PubMed ID: 6162127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM; Faull KF; Barchas JD; Berger PA
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amine metabolites in the cerbrospinal fluid in Huntington's chorea.
    Curzon G; Gumpert J; Sharpe D
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):514-9. PubMed ID: 4261957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid.
    Kartzinel R; Ebert MH; Chase TN
    Neurology; 1976 Oct; 26(10):992-6. PubMed ID: 134293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurotransmitters in Huntington chorea (review)].
    Barkhatova VP; Larskiĭ EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
    [No Abstract]   [Full Text] [Related]  

  • 34. The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
    Schildkraut JJ
    Psychopharmacol Bull; 1974 Jan; 10(1):5-25. PubMed ID: 4590871
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of Huntington's chorea: a pharmacological and clinical approach to the organization of the basal ganglia].
    Roccatagliata G; Albano C
    Clin Ter; 1980 Aug; 94(3):249-56. PubMed ID: 6450021
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of parameters for central neuronal activity in cerebrospinal fluid of rabbits following yohimbine.
    Dillen L; Claeys M; De Potter WP
    Biochem Pharmacol; 1986 Nov; 35(22):3977-82. PubMed ID: 2430573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys.
    Rogeness GA; Javors MA; Maas JW; Macedo CA; Fischer C
    Biol Psychiatry; 1987 Sep; 22(9):1158-62. PubMed ID: 3651534
    [No Abstract]   [Full Text] [Related]  

  • 38. [The Cools and van Rossum theory and the pharmacology of Huntington's chorea].
    Donatelli L
    Clin Ter; 1977 Jun; 81(5):395-416. PubMed ID: 18317
    [No Abstract]   [Full Text] [Related]  

  • 39. Huntington's chorea and lithium therapy.
    Mattsson B
    Lancet; 1973 Mar; 1(7805):718-9. PubMed ID: 4120508
    [No Abstract]   [Full Text] [Related]  

  • 40. Clonidine in the treatment of mixed bipolar disorder.
    Kontaxakis V; Markianos M; Markidis M; Stefanis C
    Acta Psychiatr Scand; 1989 Jan; 79(1):108-10. PubMed ID: 2467523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.